62 related articles for article (PubMed ID: 20044603)
1. Akt interaction with PLC(gamma) regulates the G(2)/M transition triggered by FGF receptors from MDA-MB-231 breast cancer cells.
Browaeys-Poly E; Perdereau D; Lescuyer A; Burnol AF; Cailliau K
Anticancer Res; 2009 Dec; 29(12):4965-9. PubMed ID: 20044603
[TBL] [Abstract][Full Text] [Related]
2. FGF receptor phosphotyrosine 766 is a target for Grb14 to inhibit MDA-MB-231 human breast cancer cell signaling.
Cailliau K; Perdereau D; Lescuyer A; Chen H; Garbay C; Vilain JP; Burnol AF; Browaeys-Poly E
Anticancer Res; 2005; 25(6B):3877-82. PubMed ID: 16309174
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells.
Gu X; Seong GJ; Lee YG; Kay EP
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2326-34. PubMed ID: 8843917
[TBL] [Abstract][Full Text] [Related]
4. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
5. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands.
McLeskey SW; Ding IY; Lippman ME; Kern FG
Cancer Res; 1994 Jan; 54(2):523-30. PubMed ID: 7506125
[TBL] [Abstract][Full Text] [Related]
6. Transduction cascades initiated by fibroblast growth factor 1 on Xenopus oocytes expressing MDA-MB-231 mRNAs. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma.
Browaeys-Poly E; Cailliau K; Vilain JP
Cell Signal; 2001 May; 13(5):363-8. PubMed ID: 11369518
[TBL] [Abstract][Full Text] [Related]
7. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
8. Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway.
Markova B; Albers C; Breitenbuecher F; Melo JV; Brümmendorf TH; Heidel F; Lipka D; Duyster J; Huber C; Fischer T
Oncogene; 2010 Feb; 29(5):739-51. PubMed ID: 19881535
[TBL] [Abstract][Full Text] [Related]
9. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
11. The release of fibroblast growth factor-1 from melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-kinase/Akt intracellular signaling pathway.
Di Serio C; Doria L; Pellerito S; Prudovsky I; Micucci I; Massi D; Landriscina M; Marchionni N; Masotti G; Tarantini F
Cancer Lett; 2008 Aug; 267(1):67-74. PubMed ID: 18400376
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of phospholipase C gamma 1 and its association with the FGF receptor is developmentally regulated and occurs during mesoderm induction in Xenopus laevis.
Ryan PJ; Gillespie LL
Dev Biol; 1994 Nov; 166(1):101-11. PubMed ID: 7958437
[TBL] [Abstract][Full Text] [Related]
14. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
15. Cdk4 and p27Kip1 play a role in PLC-gamma1-mediated mitogenic signaling pathway of 18 kDa FGF-2 in corneal endothelial cells.
Lee HT; Kim TY; Kay EP
Mol Vis; 2002 Feb; 8():17-25. PubMed ID: 11889462
[TBL] [Abstract][Full Text] [Related]
16. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
17. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase.
Afrasiabi E; Blom T; Balthasar S; Törnquist K
Mol Cell Endocrinol; 2007 Aug; 274(1-2):43-52. PubMed ID: 17606321
[TBL] [Abstract][Full Text] [Related]
19. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
20. Akt-induced promotion of cell-cycle progression at G2/M phase involves upregulation of NF-Y binding activity in PC12 cells.
Lee SR; Park JH; Park EK; Chung CH; Kang SS; Bang OS
J Cell Physiol; 2005 Nov; 205(2):270-7. PubMed ID: 15887249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]